PureTech Health plc
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 2210 BOSTON
- Website:
- https://puretechhealth.com/
- Sector:
- Manufacturing
Description
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-05 13:05 |
Gelesis Adds to BOD & Declared Effective by SEC
|
English | 30.7 KB | ||
| 2021-12-20 08:00 |
PDMR DEALING - PURCHASE OF SHARES
|
English | 14.7 KB | ||
| 2021-12-16 08:00 |
PRTC Provides Recap Ahead of Catalyst-Rich 2022
|
English | 33.9 KB | ||
| 2021-12-08 13:00 |
PRTC Presents Data at ACNP Conference For LYT-300
|
English | 18.0 KB | ||
| 2021-12-07 13:00 |
PRTC's Lymphatic Platform Candidate Human Study
|
English | 18.2 KB | ||
| 2021-12-01 13:10 |
PRTC: Gelesis' Plenity Now Broadly Available in US
|
English | 35.8 KB | ||
| 2021-12-01 08:00 |
Total Voting Rights
|
English | 9.1 KB | ||
| 2021-11-18 13:10 |
PRTC's Gelesis Receives $30M Plenity Order from Ro
|
English | 34.8 KB | ||
| 2021-11-16 13:00 |
PRTC Publishes Previous LYT-100 MAD Study Results
|
English | 21.4 KB | ||
| 2021-11-15 13:00 |
PRTC Presents at Two Upcoming Investor Conferences
|
English | 11.4 KB | ||
| 2021-11-12 13:00 |
PRTC Presents Immunooncology Ph 1/2 Trial at SITC
|
English | 16.8 KB | ||
| 2021-11-11 13:00 |
FDA Grants PRTC's LYT-200 Orphan Drug Designation
|
English | 14.7 KB | ||
| 2021-11-10 08:00 |
PRTC Receives $100M from Founded Entity Shares
|
English | 11.4 KB | ||
| 2021-11-09 13:34 |
KRTX and Zai Lab to Develop KarXT in Greater China
|
English | 25.6 KB | ||
| 2021-11-09 08:00 |
PRTC Presents at Jefferies Healthcare Conference
|
English | 17.5 KB |
Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PureTech Health plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PureTech Health plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
